FBR


FBR Boosts Price Target for LendingClub Corp (LC); Here’s Why

FBR analyst Bob Ramsey is out with a research report on LendingClub Corp (NYSE:LC) and ultimately remains sidelined on the fintech firm following …

FBR Weighs in on Juno Therapeutics Inc (JUNO) Following Meeting with Management

In a research report released Thursday, FBR analyst Edward White reiterated an Outperform rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO) with a price …

FBR Remains Positive on Novavax, Inc. (NVAX); Here’s Why

On October 7th, Novavax, Inc. (NASDAQ:NVAX) announced that it had rescheduled its annual investor meeting from tomorrow, October 11th and moved it to …

FBR Bullish on Rexahn Pharmaceuticals, Inc. (RNN) Ahead of ESMO Dataset Presentations

Yesterday, Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced it will be presenting preliminary data for a Phase Ib/IIa trial of metastatic pancreatic cancer drug RX-3117 …

FBR Remains Sidelined on Netflix, Inc. (NFLX) Ahead of FQ3:16 Print

FBR analyst Barton Crockett provides insight on Netflix, Inc. (NASDAQ:NFLX) ahead of third-quarter earnings set to be delivered on October 17th, reiterating a …

FBR Remains Positive on Aurinia Pharmaceuticals Inc (AUPH) Following Clinical Update in Lupus Nephritis

FBR analyst Vernon Bernardino was out with a research note on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) after the company announced updated results from its AURALV Phase …

FBR Chimes in on Ballard Power Systems Inc. (USA) (BLDP) Amid Accelerating Automotive Development Work with Volkswagen/Audi

Yesterday, Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) indicated it had received an undisclosed amount of purchase orders to accelerate fuel stack development work …

FBR Chimes in on Kite Pharma Inc (KITE) Following Positive ZUMA-1 Pivotal Trial Read-Out

Yesterday, Kite Pharma Inc (NASDAQ:KITE) announced positive top-line interim results from its ZUMA-1 pivotal trial in patients with aggressive Non-Hodgkin’s lymphoma (NHL). At …

FBR Weighs in on Anavex Life Sciences Corp. (AVXL) Following Positive Preclinical Data

Yesterday morning, Anavex Life Sciences Corp (NASDAQ:AVXL) presented positive data after investigating its pipeline drug Anavex 2073, a sigma-1 receptor antagonist that could …

FBR Capital Initiates Underperform On Chesapeake Energy Shares; Sees 36% Downside For The Stock

FBR analyst Joseph Allman initiates coverage on shares of Chesapeake Energy Corporation (NYSE:CHK) with an Underperform rating and a $5 price target, which …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts